Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Pharmacodynamics and Pharmacokinetics of Citalopram and Escitalopram.

Trial Profile

Pharmacodynamics and Pharmacokinetics of Citalopram and Escitalopram.

Completed
Phase of Trial: Phase I

Latest Information Update: 17 Feb 2014

At a glance

  • Drugs Citalopram (Primary) ; Escitalopram (Primary)
  • Indications Major depressive disorder
  • Focus Pharmacogenomic; Therapeutic Use
  • Acronyms PGRN-AMPS
  • Most Recent Events

    • 01 May 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 18 Oct 2012 Planned end date changed from 1 Feb 2020 to 1 Dec 2012 as reported by ClinicalTrials.gov.
    • 18 Oct 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top